Видео ютуба по тегу T-Dm1

HER2+ Breast Cancer: Managing Patients on T-DM1
HER2+ Breast Cancer: Managing Patients on T-DM1
Adjuvant T-DM1 Therapy for Early-Stage HER2+ Breast Cancer
Adjuvant T-DM1 Therapy for Early-Stage HER2+ Breast Cancer
T-DXd против T-DM1 при HER2+ раке молочной железы высокого риска: промежуточные данные DESTINY-Br...
T-DXd против T-DM1 при HER2+ раке молочной железы высокого риска: промежуточные данные DESTINY-Br...
Case Review: T-DM1 for Residual HER2+ Breast Cancer
Case Review: T-DM1 for Residual HER2+ Breast Cancer
EMILIA Trial: T-DM1 in Metastatic Breast Cancer
EMILIA Trial: T-DM1 in Metastatic Breast Cancer
T-DM1 improves overall survival in previously treated advanced cancer patients
T-DM1 improves overall survival in previously treated advanced cancer patients
How Breast Cancer Treatment Kadcyla (T-DM1) Works
How Breast Cancer Treatment Kadcyla (T-DM1) Works
Neoadjuvant T-DM1 in HER2+ Early Breast Cancer
Neoadjuvant T-DM1 in HER2+ Early Breast Cancer
Dr Tarantino on the Safety of T-DXd and T-DM1 in HER2+ Breast Cancer
Dr Tarantino on the Safety of T-DXd and T-DM1 in HER2+ Breast Cancer
T-DM1 Plus Pertuzumab in the MARIANNE Trial
T-DM1 Plus Pertuzumab in the MARIANNE Trial
Dr. Julie Gralow Discusses T-DM1-Induced Thrombocytopenia
Dr. Julie Gralow Discusses T-DM1-Induced Thrombocytopenia
5-year correlative analysis of ATEMPT: adjuvant T-DM1 vs paclitaxel+trastuzumab for stage I HER2+ BC
5-year correlative analysis of ATEMPT: adjuvant T-DM1 vs paclitaxel+trastuzumab for stage I HER2+ BC
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
Dr. Louis Weiner on the T-DM1 Mechanism of Action in HER2-Positive Breast Cancer
Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment
Dr. Yorio on T-DM1 in HER2-Mutant Lung Cancer Treatment
Benefit of Antibody Drug Conjugate T-DM1 in HER2+ BC
Benefit of Antibody Drug Conjugate T-DM1 in HER2+ BC
The New T-DM1 Breast Cancer Drug, An Oncologist's Reaction
The New T-DM1 Breast Cancer Drug, An Oncologist's Reaction
Dr. Burris Discusses Promise of T-DM1 in HER2+ Breast Cancer
Dr. Burris Discusses Promise of T-DM1 in HER2+ Breast Cancer
Phase 3 Trial Investigates T-DM1 and Pertuzumab in HER2+ Breast Cancer
Phase 3 Trial Investigates T-DM1 and Pertuzumab in HER2+ Breast Cancer
T-DM1 may extend PFS among patients with unresectable locally advanced or metastatic HER2-positi...
T-DM1 may extend PFS among patients with unresectable locally advanced or metastatic HER2-positi...
Upfront T-DM1 in HER2-Positive Breast Cancer
Upfront T-DM1 in HER2-Positive Breast Cancer